Sonnet BioTherapeutics (SONN) Insider Trading & Ownership $1.56 -0.03 (-1.89%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Sonnet BioTherapeutics (NASDAQ:SONN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.00%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$105,416.74Number OfInsiders Selling(Last 3 Years)0 Get SONN Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonnet BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SONN Insider Buying and Selling by Quarter Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Sonnet BioTherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2023Susan DexterInsiderBuy454$15.40$6,991.60 5/30/2023Albert D DyrnessDirectorBuy1,057$10.34$10,929.38 5/17/2023Nailesh BhattDirectorBuy1,136$5.06$5,748.16 5/15/2023Pankaj MohanCEOBuy16,890$4.84$81,747.60 (Data available from 1/1/2013 forward) SONN Insider Trading Activity - Frequently Asked Questions Who is on Sonnet BioTherapeutics's Insider Roster? The list of insiders at Sonnet BioTherapeutics includes Albert D Dyrness, Nailesh Bhatt, Pankaj Mohan, and Susan Dexter. Learn more on insiders at SONN. What percentage of Sonnet BioTherapeutics stock is owned by insiders? 2.00% of Sonnet BioTherapeutics stock is owned by insiders. Learn more on SONN's insider holdings. Which Sonnet BioTherapeutics insiders have been buying company stock? The following insiders have purchased SONN shares in the last 24 months: Albert D Dyrness ($10,929.38), Nailesh Bhatt ($5,748.16), Pankaj Mohan ($81,747.60), and Susan Dexter ($6,991.60). How much insider buying is happening at Sonnet BioTherapeutics? Insiders have purchased a total of 19,537 SONN shares in the last 24 months for a total of $105,416.74 bought. Sonnet BioTherapeutics Key ExecutivesDr. Pankaj Mohan Ph.D. (Age 59)Founder, Chairman, CEO & President Compensation: $927kDr. John K. Cini Ph.D. (Age 71)Chief Scientific Officer & Co-Founder Compensation: $602.48kMr. Jay Cross (Age 53)Chief Financial Officer Compensation: $603.42kMr. Donald J. Griffith CPA (Age 75)CPA, Controller & Director Compensation: $134.05kMs. Susan Dexter (Age 69)Chief Technical Officer Dr. Richard T. Kenney FACP (Age 66)M.D., Chief Medical Officer Mr. Manuel DafonsecaHead of Clinical Operations More Insider Trading Tools from MarketBeat Related Companies RNAZ Insider Ownership ALZN Insider Ownership ORGS Insider Ownership LIXT Insider Ownership ADTX Insider Ownership FRTX Insider Ownership CELZ Insider Ownership OGEN Insider Ownership SNPX Insider Ownership HEPA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:SONN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
